Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)

Autor: Palmieri, G. *, Merola, G., Federico, P., Petillo, L., Marino, M., Lalle, M., Milella, M., Ceribelli, A., Montella, L., Merola, C., Del Prete, S., Bergaglio, M., De Placido, S., Di Lorenzo, G.
Zdroj: In Annals of Oncology June 2010 21(6):1168-1172
Databáze: ScienceDirect